ChemiCare is committed to the discovery and development of orphan drugs for patients affected by calcium-related genetic diseases.
ChemiCare has raised $2.9M in total funding. The most recent round was Seed. The last funding was announced in December 2025.
ChemiCare's investors include CDP Venture Capital, Bio4Dreams, EASME, Bridge4Pharma.
ChemiCare is headquartered in Novara, Italy.
ChemiCare is committed to the discovery and development of orphan drugs for patients affected by calcium-related genetic diseases.
ChemiCare is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"ChemiCare — Funding & Investors." VCBacked, December 18, 2025, https://www.vcbacked.co/company/chemicare. Accessed July 19, 2026.
VCBacked. (2025). ChemiCare — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/chemicare
{{cite web |title=ChemiCare — Funding & Investors |url=https://www.vcbacked.co/company/chemicare |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated